Neurocrine Biosciences, Inc.
(NASDAQ : NBIX)

( )
NBIX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -2.82%72.010.0%$2372.81m
NVAXNovavax, Inc. 4.83%178.51251.8%$1337.92m
SRNESorrento Therapeutics, Inc. 30.51%18.821.5%$899.58m
GILDGilead Sciences, Inc. -1.21%68.511.0%$564.29m
AMGNAmgen, Inc. -1.05%238.171.3%$477.09m
REGNRegeneron Pharmaceuticals, Inc. -1.93%608.242.7%$403.31m
BNTXBioNTech SE -3.96%73.950.0%$397.67m
VRTXVertex Pharmaceuticals, Inc. -1.56%268.731.9%$369.46m
BIIBBiogen, Inc. -1.78%300.261.6%$363.67m
ILMNIllumina, Inc. -0.65%353.353.5%$342.14m
VXRTVaxart, Inc. 2.23%9.400.0%$296.32m
EBSEmergent BioSolutions, Inc. -0.19%130.416.4%$188.70m
ALXNAlexion Pharmaceuticals, Inc. -1.36%101.882.0%$166.53m
IBIOiBio, Inc. -3.16%3.680.2%$166.50m
SGENSeattle Genetics, Inc. -1.71%157.706.2%$160.68m

Company Profile

Neurocrine Biosciences, Inc. operates as a product based bio-pharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company product includes INGREZZA. Neurocrine Biosciences was founded by Kevin C. Gorman and Wylie W. Vale on January 1992 and is headquartered in San Diego, CA.